{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:13:58Z","timestamp":1792502038319,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"am","delay-in-days":284,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["GINTR0133D"],"award-info":[{"award-number":["GINTR0133D"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA015815"],"award-info":[{"award-number":["UG1DA015815"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030605","name":"Oregon Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR002370"],"award-info":[{"award-number":["KL2TR002370"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UH3DA044831"],"award-info":[{"award-number":["UH3DA044831"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.josat.2024.209510","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T20:05:51Z","timestamp":1725653151000},"page":"209510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Peer-Assisted Telemedicine for Hepatitis C (PATHS): Process evaluation results from a State Opioid Response-funded program"],"prefix":"10.1016","volume":"167","author":[{"given":"Hunter","family":"Spencer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Leichtling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Babiarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Herink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonhi","family":"Gailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Leahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Todd","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.josat.2024.209510_bb0005","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.drugpo.2015.05.003","article-title":"Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C","volume":"26","author":"Alavi","year":"2015","journal-title":"The International Journal on Drug Policy"},{"issue":"23","key":"10.1016\/j.josat.2024.209510_bb0010","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1056\/NEJMoa1009370","article-title":"Outcomes of treatment for hepatitis C virus infection by primary care providers","volume":"364","author":"Arora","year":"2011","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.josat.2024.209510_bb0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/jvh.13233","article-title":"Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study","volume":"27","author":"Bajis","year":"2020","journal-title":"Journal of Viral Hepatitis"},{"issue":"6","key":"10.1016\/j.josat.2024.209510_bb0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/jama.2014.8897","article-title":"New expensive treatments for hepatitis C infection","volume":"312","author":"Brennan","year":"2014","journal-title":"Jama"},{"issue":"11","key":"10.1016\/j.josat.2024.209510_bb0025","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMra2033539","article-title":"Extrahepatic manifestations of chronic HCV infection","volume":"384","author":"Cacoub","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.josat.2024.209510_bb0030","series-title":"Viral hepatitis surveillance \u2014 United States, 2021","author":"Centers for Disease Control and Prevention","year":"2023"},{"issue":"2","key":"10.1016\/j.josat.2024.209510_bb0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/nhs.12173","article-title":"Experiences of UK patients with hepatitis C virus infection accessing phlebotomy: A qualitative analysis","volume":"17","author":"Clements","year":"2015","journal-title":"Nursing & Health Sciences"},{"issue":"7","key":"10.1016\/j.josat.2024.209510_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/v14071555","article-title":"A testing campaign intervention consisting of peer-facilitated engagement, point-of-care HCV RNA testing, and linkage to nursing support to enhance hepatitis C treatment uptake among people who inject drugs: the ETHOS engage study","volume":"14","author":"Conway","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.josat.2024.209510_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108525","article-title":"Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington","volume":"220","author":"Corcorran","year":"2021","journal-title":"Drug Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.josat.2024.209510_bb0050","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/jvh.13583","article-title":"Hepatitis C virus care cascade in persons experiencing homelessness in the United States in the era of direct-acting antiviral agents: A scoping review","volume":"28","author":"Del Rosario","year":"2021","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.josat.2024.209510_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104185","article-title":"Peer-delivered point-of-care testing and linkage to treatment for hepatitis C virus infection among marginalized populations through a mobile clinic in Copenhagen, Denmark","volume":"121","author":"Demant","year":"2023","journal-title":"International Journal on Drug Policy"},{"issue":"2","key":"10.1016\/j.josat.2024.209510_bb0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.amepre.2020.08.031","article-title":"Changing urban-rural disparities in the utilization of direct-acting antiviral agents for hepatitis C in U.S. Medicare patients, 2014\u20132017","volume":"60","author":"Du","year":"2021","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.josat.2024.209510_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2024.209309","article-title":"Statewide efforts to address the opioid epidemic: Results from a national survey of single state agencies","volume":"160","author":"Estrada","year":"2024","journal-title":"Journal of Substance Use and Addiction Treatment"},{"issue":"10","key":"10.1016\/j.josat.2024.209510_bb0070","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1111\/liv.14634","article-title":"Hepatitis C treatment uptake among people who inject drugs in the oral direct-acting antiviral era","volume":"40","author":"Falade-Nwulia","year":"2020","journal-title":"Liver International"},{"issue":"9","key":"10.1016\/j.josat.2024.209510_bb0075","doi-asserted-by":"crossref","first-page":"ofac445","DOI":"10.1093\/ofid\/ofac445","article-title":"The hepatitis C care cascade during the direct-acting antiviral era in a United States commercially insured population","volume":"9","author":"Ferrante","year":"2022","journal-title":"Open Forum Infectious Diseases"},{"issue":"1","key":"10.1016\/j.josat.2024.209510_bb0080","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13722-023-00384-z","article-title":"A randomized controlled trial for a peer-facilitated telemedicine hepatitis C treatment intervention for people who use drugs in rural communities: Study protocol for the \u201cpeer tele-HCV\u201d study","volume":"18","author":"Herink","year":"2023","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"10.1016\/j.josat.2024.209510_bb0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12954-023-00762-5","article-title":"Ultrasound-guided phlebotomy in primary care for people who inject drugs","volume":"20","author":"Huyck","year":"2023","journal-title":"Harm Reduction Journal"},{"issue":"7","key":"10.1016\/j.josat.2024.209510_bb0090","doi-asserted-by":"crossref","first-page":"e2011055","DOI":"10.1001\/jamanetworkopen.2020.11055","article-title":"Association of direct-acting antiviral treatment with mortality among Medicare beneficiaries with hepatitis C","volume":"3","author":"Kalidindi","year":"2020","journal-title":"JAMA Network Open"},{"issue":"2","key":"10.1016\/j.josat.2024.209510_bb0095","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/gastroent12020016","article-title":"Telehealth as an important player in the management of hepatitis C virus","volume":"12","author":"Khoja","year":"2021","journal-title":"Gastroenterology Insights"},{"key":"10.1016\/j.josat.2024.209510_bb0100","series-title":"47th annual conference of the association for multidisciplinary education and research in substance use and addition, Washington, DC","article-title":"A community peer recovery support specialist model for engaging people who use drugs in rural communities","author":"Korthuis","year":"2023"},{"key":"10.1016\/j.josat.2024.209510_bb0105","series-title":"The improvement guide: A practical approach to enhancing organizational performance","author":"Langley","year":"2009"},{"issue":"5","key":"10.1016\/j.josat.2024.209510_bb0110","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/cid\/ciz976","article-title":"Deaths associated with hepatitis C virus infection among residents in 50 states and the District of Columbia, 2016\u20132017","volume":"71","author":"Ly","year":"2020","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"10.1016\/j.josat.2024.209510_bb0115","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1007\/s11606-019-05291-1","article-title":"Impact of project ECHO models of medical tele-education: A systematic review","volume":"34","author":"McBain","year":"2019","journal-title":"Journal of General Internal Medicine"},{"issue":"10","key":"10.1016\/j.josat.2024.209510_bb0120","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.38792","article-title":"Community-based point-of-diagnosis hepatitis c treatment for marginalized populations: A nonrandomized controlled trial","volume":"6","author":"Morris","year":"2023","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2024.209510_bb0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2019.02.008","article-title":"Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated","volume":"198","author":"Morris","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.josat.2024.209510_bb0130","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1258\/jrsm.2011.110180","article-title":"The answer is 17\u00a0years, what is the question: Understanding time lags in translational research","volume":"104","author":"Morris","year":"2011","journal-title":"Journal of the Royal Society of Medicine"},{"issue":"2","key":"10.1016\/j.josat.2024.209510_bb0135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jamainternmed.2022.5699","article-title":"Association of direct-acting antiviral therapy with liver and nonliver complications and long-term mortality in patients with chronic hepatitis C","volume":"183","author":"Ogawa","year":"2023","journal-title":"JAMA Internal Medicine"},{"issue":"14","key":"10.1016\/j.josat.2024.209510_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/WVVL4786","article-title":"A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: The SHARPS feasibility mixed-methods study","volume":"26","author":"Parkes","year":"2022","journal-title":"Health Technology Assessment"},{"issue":"2","key":"10.1016\/j.josat.2024.209510_bb0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11904-018-0390-3","article-title":"The syndemic of opioid misuse, overdose, HCV, and HIV: Structural-level causes and interventions","volume":"15","author":"Perlman","year":"2018","journal-title":"Current HIV\/AIDS Reports"},{"issue":"3","key":"10.1016\/j.josat.2024.209510_bb0150","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/add.14012","article-title":"Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: Findings from a Cochrane review and meta-analysis","volume":"113","author":"Platt","year":"2018","journal-title":"Addiction"},{"issue":"25","key":"10.1016\/j.josat.2024.209510_bb0155","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMcp1006613","article-title":"Clinical practice. Chronic hepatitis C infection","volume":"364","author":"Rosen","year":"2011","journal-title":"The New England Journal of Medicine"},{"issue":"8","key":"10.1016\/j.josat.2024.209510_bb0160","doi-asserted-by":"crossref","first-page":"e186371","DOI":"10.1001\/jamanetworkopen.2018.6371","article-title":"Prevalence of hepatitis C virus infection in US States and the District of Columbia, 2013 to 2016","volume":"1","author":"Rosenberg","year":"2018","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2024.209510_bb0165","author":"Save Lives Oregon"},{"key":"10.1016\/j.josat.2024.209510_bb0170","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae520","article-title":"Peer-assisted telemedicine for hepatitis C in people who use drugs: A randomized controlled trial","author":"Seaman","year":"2024","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1016\/j.josat.2024.209510_bb0175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12954-022-00619-3","article-title":"Peer-facilitated treatment access for hepatitis C: The Live Hep C Free project","volume":"19","author":"Silano","year":"2022","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2024.209510_bb0180","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.drugalcdep.2018.06.013","article-title":"\u2018Hep C\u2019s like the common cold\u2019: Understanding barriers along the HCV care continuum among young people who inject drugs","volume":"190","author":"Skeer","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.josat.2024.209510_bb0185","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/08897077.2020.1846149","article-title":"System-level factors shaping the implementation of \u201chub and spoke\u201d systems to expand MOUD in rural areas","volume":"42","author":"Snell-Rood","year":"2021","journal-title":"Substance Abuse"},{"issue":"2","key":"10.1016\/j.josat.2024.209510_bb0190","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/cid\/ciy899","article-title":"Integrated, co-located, telemedicine-based treatment approaches for hepatitis C virus management in opioid use disorder patients on methadone","volume":"69","author":"Talal","year":"2019","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.josat.2024.209510_bb0195","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.2452","article-title":"Integrated hepatitis C\u2013opioid use disorder care through facilitated telemedicine: A randomized trial","author":"Talal","year":"2024","journal-title":"Jama"},{"key":"10.1016\/j.josat.2024.209510_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.109878","article-title":"Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugs","volume":"247","author":"Tsui","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2024.209510_bb0205","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/liv.15095","article-title":"Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point-of-care","volume":"42","author":"Valencia","year":"2022","journal-title":"Liver International"},{"issue":"3","key":"10.1016\/j.josat.2024.209510_bb0210","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAI.0000000000001098","article-title":"County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States","volume":"73","author":"Van Handel","year":"2016","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"26","key":"10.1016\/j.josat.2024.209510_bb0215","doi-asserted-by":"crossref","first-page":"716","DOI":"10.15585\/mmwr.mm7226a3","article-title":"Hepatitis C virus clearance cascade \u2014 United States, 2013\u20132022","volume":"72","author":"Wester","year":"2023","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"10.1016\/j.josat.2024.209510_bb0220","series-title":"Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030","author":"World Health Organization","year":"2022"},{"issue":"7","key":"10.1016\/j.josat.2024.209510_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101554","article-title":"The treatment cascade for chronic hepatitis C virus infection in the United States: A systematic review and meta-analysis","volume":"9","author":"Yehia","year":"2014","journal-title":"PLoS One"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924002224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875924002224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T21:32:48Z","timestamp":1732743168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875924002224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":45,"alternative-id":["S2949875924002224"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2024.209510","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peer-Assisted Telemedicine for Hepatitis C (PATHS): Process evaluation results from a State Opioid Response-funded program","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2024.209510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209510"}}